| # | Drug | Count |
|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 242 |
| 1 | ETANERCEPT | 143 |
| 2 | INSULIN GLARGINE | 55 |
| 3 | INSULIN ASPART | 46 |
| 4 | INSULIN DEGLUDEC | 36 |
| 5 | ADALIMUMAB | 27 |
| 6 | METHOTREXATE | 26 |
| 7 | METHOTREXATE SODIUM | 26 |
| 8 | LISINOPRIL | 25 |
| 9 | GABAPENTIN | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | 1 | 0.5000 |
| 1 | DIMETICONE | 1 | 0.0035 |
| 2 | ORAL SEMAGLUTIDE | 242 | 0.0031 |
| 3 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 1 | 0.0023 |
| 4 | BUPROPION HYDROBROMIDE | 1 | 0.0017 |
| 5 | FOSFOMYCIN TROMETHAMINE | 1 | 0.0016 |
| 6 | BUTALBITAL AND ACETAMINOPHEN | 1 | 0.0016 |
| 7 | INSULIN DEGLUDEC | 36 | 0.0015 |
| 8 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0013 |
| 9 | INSULIN ASPART INJECTION | 3 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 266 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 149 |
| 2 | Insulin Analog [EPC] | 137 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 4 | Benzodiazepine [EPC] | 45 |
| 5 | Corticosteroid [EPC] | 40 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 26 |
| 7 | Atypical Antipsychotic [EPC] | 25 |
| 8 | Proton Pump Inhibitor [EPC] | 24 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 1 | GLP-1 Receptor Agonist [EPC] | 266 | 0.0006 |
| 2 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 3 | PCSK9 Inhibitor [EPC] | 11 | 0.0004 |
| 4 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 6 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 7 | Insulin Analog [EPC] | 137 | 0.0003 |
| 8 | Anticholinergic [EPC] | 3 | 0.0002 |
| 9 | Pyrimidine Synthesis Inhibitor [EPC] | 7 | 0.0002 |